Seeking Alpha

Obagi Medical (OMPI +7.7%) moves up today after topping Q4 estimates late yesterday. Looking...

Obagi Medical (OMPI +7.7%) moves up today after topping Q4 estimates late yesterday. Looking forward, the company sees FY13 earnings of $0.80 to $0.84 per share on $126M to $130M. The Street is at $0.88 per share and $128.31M in revenue. Cantor Fitzgerald upgraded the shares to Buy on the back of the report and raised its price target from $15.00 to $19.00, noting a 50% probability of a takeout in the $21 range.
Comments (1)
  • GaryLee276
    , contributor
    Comments (152) | Send Message
     
    I bought OMPI because it was a solid stock with a possibility it might be bought out. So far so good. Help me please!!!!
    15 Mar 2013, 11:47 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|